AEON Biopharma, Inc.
AEON · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $8 | $2 | $22 |
| - Cash | $6 | $8 | $10 | $0 |
| + Debt | $18 | $16 | $15 | $13 |
| Enterprise Value | $21 | $16 | $6 | $34 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$4 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$7 | $9 | $2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.39 | -0.6 | 2.28 | 3.47 |
| % Growth | 35% | -126.3% | -34.3% | – |
| Operating Cash Flow | -$3 | -$2 | -$8 | -$1 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$3 | -$2 | -$8 | -$1 |